Your browser doesn't support javascript.
loading
The health and economic burden of pertussis in Canada: A microsimulation study.
McGirr, Ashleigh; Fisman, David N; Tuite, Ashleigh R.
Affiliation
  • McGirr A; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Fisman DN; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada. Electronic address: david.fisman@utoronto.ca.
  • Tuite AR; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Vaccine ; 37(49): 7240-7247, 2019 11 20.
Article in En | MEDLINE | ID: mdl-31585727
ABSTRACT

BACKGROUND:

Despite excellent vaccine coverage, pertussis persists in Canada, with high incidence during recent outbreaks and non-negligible incidence in non-outbreak years. While Canadian pertussis incidence is well-characterized, the full health and economic impact of pertussis have not been examined in Canada. We estimated age-specific life years (LYs) and quality-adjusted life years (QALYs) lost, and costs due to pertussis in Ontario, Canada, using a model-based approach.

METHODS:

We developed a microsimulation model to simulate pertussis natural history. Daily probabilities of pertussis complications, hospitalizations, and disease sequelae as well as utilities and costs for health states were literature-derived. A healthcare payer perspective was used with a lifetime time horizon. Model outcomes were compared to those from a model with no pertussis health states. Probabilistic sensitivity analyses were used to generate distributions for estimates. Economic burden was estimated by multiplying case cost estimates by annual age-specific incidence.

RESULTS:

Overall, LYs lost per pertussis case was low, with negligible LYs lost in those aged >4 years. Infants (<6 months) had the greatest mean QALY loss per case (0.58), while adults lost only 0.05 QALYs per case. Infants experienced the greatest mean cost per case of $22,768 (95% CI 21,144-23,406). Case costs generally declined with age, but increased in seniors (aged 65+) with mean cost of $1920 (95% CI 1800-2033). Based on historic age-specific incidence, pertussis costs the Ontario healthcare system approximately $7.6-$21.5 M annually. In total economic cost estimates with QALYs valued at 1xGDP (3xGDP) per capita, the net impact of pertussis in Ontario was estimated at $21.7-$66.5 M annually ($50.0-$156.3 M). For all of Canada, total economic costs were estimated at $79.6-$241.3 M ($187.5-$580.5 M) annually.

CONCLUSION:

The health and economic consequences of pertussis persistence are substantial and highlight the need for improved control strategies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Whooping Cough / Health Care Costs / Cost of Illness / Quality-Adjusted Life Years / Diphtheria-Tetanus-acellular Pertussis Vaccines Type of study: Health_economic_evaluation / Incidence_studies / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2019 Document type: Article Affiliation country: Canadá

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Whooping Cough / Health Care Costs / Cost of Illness / Quality-Adjusted Life Years / Diphtheria-Tetanus-acellular Pertussis Vaccines Type of study: Health_economic_evaluation / Incidence_studies / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Vaccine Year: 2019 Document type: Article Affiliation country: Canadá